Log in

Relevant bibliographies by topics / Human ovarian carcinoma cells / Books

To see the other types of publications on this topic, follow the link: Human ovarian carcinoma cells.

Books on the topic 'Human ovarian carcinoma cells'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 16 books for your research on the topic 'Human ovarian carcinoma cells.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Byrne, Karen. Targeting of radiolabelled antibodies to ovarian carcinoma cells and spheroids. University of Manchester, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Weinstein, Ellen Michele. Inhibition of CA 125, a novel high molecular weight glycoprotein expressed by an ovarian carcinoma cell line: 0VCA 433, is related to glucocorticoid effects of altered cell growth, morphology, and growth pattern. s.n.], 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Linda, Giudice, Santa Eileen, Pool Robert, Institute of Medicine (U.S.). Board on Health Sciences Policy, and National Research Council (U.S.). Board on Life Sciences., eds. Assessing the medical risks of human oocyte donation for stem cell research: Workshop report. National Academies Press, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

K, Woodruff Teresa, and Snyder Karrie Ann, eds. Oncofertility: Fertility preservation for cancer survivors. Springer Verlag, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

1963-, Woodruff Teresa K., and Snyder Karrie Ann, eds. Oncofertility: Fertility preservation for cancer survivors. Springer, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hayat, M. A. Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas: Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma. Elsevier Science & Technology Books, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sheldon, Katherine Mary. Characterization of immunoconjugates active against human carcinoma cells "in vitro". 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Josephs, Debra H., Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis. Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0001.

Full text

Abstract:

Despite improvements over the past decade in the treatment of ovarian cancer, many patients are at risk of recurrent disease and emerging drug resistance. The increased selectivity and reduced toxicity of molecularly targeted anti-cancer agents renders them attractive for development in ovarian cancer, and monoclonal antibodies targeting ovarian cancer-specific tumor antigens represent the largest such group investigated in this clinical setting. This chapter describes examples of monoclonal antibodies clinically evaluated for efficacy in ovarian cancer. These agents recognize molecular target

APA, Harvard, Vancouver, ISO, and other styles

9

Jakobson, Eva. Studies on positive and negative growth regulation in human bladder carcinoma cells. 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hayat, M. A. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 4: Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma ... in Situ Hybridization of Human Carcinomas). Academic Press, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Hayat, M. A. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 4: Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma ... in Situ Hybridization of Human Carcinomas). Academic Press, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Farghaly, Samir A., ed. Ovarian Cancer Immunotherapy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.001.0001.

Full text

Abstract:

Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more. Readers will also gain a better understanding of the molecul

APA, Harvard, Vancouver, ISO, and other styles

13

Jong, Steven de. Cell biological aspects of drug-resistance in human small cell lung carcinoma cells. 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Zhang, Zhifen. Detection of M-CSF and its receptor in huma follicular granulosa cells: Expression patterns of M-CSF in human ovarian follicular fluid and serum. 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Farghaly, Samir A. Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0005.

Full text

Abstract:

The standard management for epithelial ovarian cancer (EOC) is a combination of aggressive debulking surgery with residual tumor of less than 1 cm and platinum-based chemotherapy. However, a high percentage of patients experience disease recurrence. Extensive efforts to find new therapeutic options have been made, albeit cancer cells develop drug resistance and malignant progression occurs. Novel therapeutic strategies are needed to enhance progression-free survival and overall survival of patients with advanced EOC. Several preclinical and clinical studies investigated feasibility and efficac

APA, Harvard, Vancouver, ISO, and other styles

16

Lee, Gregory. Epitope/Peptide-Based Monoclonal Antibodies for Immunotherapy of Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0007.

Full text

Abstract:

Two monoclonal antibodies, RP215 and GHR106, were selected, respectively, for the research and development of anti-cancer drugs targeting ovarian cancer and other types of human cancer. RP215 was shown to react with a carbohydrate-associated epitope located mainly in the variable regions of immunoglobulin heavy chains expressed on the surface of almost all cancer cells in humans. GHR106 was generated against a synthetic peptide corresponding to N1-29 amino acid residues in the extracellular domains of human GnRH receptor, which is surface-expressed by most cancer cells as well as the anterior

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!